Discontinued — last reported Q4 '25
Carrier Global Acquisitions increased by 53.3% to $23.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 91.7%, from $12.00M to $23.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -26.5% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $161.00M | $47.00M | $152.00M | $9.00M | $29.00M | $434.00M | $34.00M | $52.00M | $4.00M | $13.00M | $15.00M | $10.77B | $7.00M | $94.00M | $17.00M | $12.00M | $49.00M | $31.00M | $15.00M | $23.00M |
| QoQ Change | — | -70.8% | +223.4% | -94.1% | +222.2% | >999% | -92.2% | +52.9% | -92.3% | +225.0% | +15.4% | >999% | -99.9% | >999% | -81.9% | -29.4% | +308.3% | -36.7% | -51.6% | +53.3% |
| YoY Change | — | — | — | — | -82.0% | +823.4% | -77.6% | +477.8% | -86.2% | -97.0% | -55.9% | >999% | +75.0% | +623.1% | +13.3% | -99.9% | +600.0% | -67.0% | -11.8% | +91.7% |